The 30th APSAD conference Scientific Program Committee call for abstracts is now closed.
Abstract review notification
Abstract review notification, program scheduling and allocated presentation format will be communicated to the corresponding authors email address by 1 August 2010. Please note, the details provided as the author contact should be for the nominated main contact for your abstract. All correspondence relating to the submission will be directed to this person, and they should in turn distribute to any/all co-presenters.
Please note, acceptance of an abstract within the conference program does not constitute an offer to pay travel, accommodation and/or registration costs associated with the conference. Similarly, no presenter fee is paid to successful participants. All presenters must register for the conference and forward the appropriate registration fee at least six weeks prior to the commencement of the conference.
Publication of abstracts
Abstracts submitted will be published in a supplement of the Drug and Alcohol Review distributed at the conference. The Drug and Alcohol Review is APSAD’s official journal and is Asia-Pacific’s leading multidisciplinary journal addressing issues related to alcohol and drug-related problems. Published bi-monthly as of 2005, the Drug and Alcohol Review presents original research, policy development and information in the drug and alcohol research field. The journal is an international forum for the views, expertise and experience of all those involved in the study of treatment of alcohol, tobacco and drug problems. The journal represents an important source of information to clinicians, drug and alcohol agency staff, researchers, policy makers, and alcohol service administrators. Please consider this when writing your abstract, structure it accordingly (including any relevant data) and proofread abstracts carefully to avoid errors before submission. Proof pages will be sent to authors in mid October, it is the author’s responsibility to review proofs and return any corrections by the due date. Change in data or abstract content is not permitted at proof stage. Revisions to abstracts will not be permitted after Friday 28 May 2010, submission deadline. For further information please contact the Drug and Alcohol Review editorial officer.
